Breaking News

Algorithme Expands Montreal Clinical Facility

By Kristin Brooks | January 31, 2014

New Unit brings total beds to 265

Algorithme Pharma is expanding its clinical facility in Montreal, Quebec, with a seventh clinical unit, for a total 265 beds. The open concept design has three independent lounges, soundproof dormitories and facility-wide WiFi, and aims to provide sponsors with increased flexibility and efficiency for conducting complex study designs requiring large panel sizes.
 
Ingrid Holmes, vice president Clinical Operations, Algorithme Pharma, commented, “In response to our sponsors’ early phase development needs, we’ve added 41 hospital beds to our existing footprint. The new clinic is a great addition to our existing facility. The flexibility in the open concept design allows for increasingly complex protocol functions to occur either in a common area or at the bedside. This design feature, coupled with the ability to perform studies requiring intensive safety monitoring, makes this a unique space. The clinic has been designed for safety, functionality and the comfort of our study participants, and will allow us to continue to increase our service offering in the early phase market.”

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016